All Clinical Trials in Canada

A listing of 3905 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

Canada

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

NCT06112314

Recruiting

This is a phase 3, randomized, controlled study of brenetafusp (IMC-F106C) plus nivolumab compared to standard nivolumab regimens in HLA-A\*02:01-positive participants with previously untreated advanced melanoma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/23/2025

Locations: University of Arizona, Tucson, Arizona +173 locations

University of Arizona, Tucson, Arizona

University of California - San Diego, La Jolla, California

The Angeles Clinic and Research Institute- West Los Angeles, Los Angeles, California

ESC Norris Comprehensive Cancer Center, Los Angeles, California

UCLA Hematology/Oncology, Los Angeles, California

Stanford Cancer Institute - Stanford Cancer Center Palo Alto, Palo Alto, California

Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica, California

University of Colorado, Anschutz Medical Campus, Aurora, Colorado

UConn Health-Farmington (University of Connecticut Health Center (UCHC)), Farmington, Connecticut

Georgetown University, Washington, District of Columbia

Mayo Clinic Florida, Jacksonville, Florida

University of Miami Health System-Sylvester Comprehensive Cancer Center-Miami, Miami, Florida

Northwestern University - Robert H. Lurie Comprehensive Cancer Center - NMDTI, Chicago, Illinois

The University of Kansas Cancer Center (KUCC) - Westwood, Westwood, Kansas

St. Elizabeth Healthcare - Edgewood, Edgewood, Kentucky

Dana Farber Cancer Institute, Boston, Massachusetts

Washington University School of Medicine, Saint Louis, Missouri

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey

Northwell Health Cancer Institute, Lake Success, New York

Columbia University Medical Center, New York, New York

Thomas Jefferson University, Philadelphia, Pennsylvania

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania

Prisma Health Cancer Institute, Greenville, South Carolina

Spartanburg Regional Healthcare System - Spartanburg Medical Center (SMC), Spartanburg, South Carolina

Sarah Cannon Research Institute: USA/TN, Nashville, Tennessee

University of Utah Huntsman Cancer Institute, Salt Lake City, Utah

UVA Health-UVA Emily Couric Clinical Cancer Center, Charlottesville, Virginia

Swedish Medical Center - Swedish Cancer Institute (SCI) - First Hill Campus, Seattle, Washington

Sanatorio Finochietto, Caba, Buenos Aires

Clínica Adventista Belgrano - Sector Investigación, Caba, Buenos Aires

Instituto Alexander Fleming, Caba, Not set

CEMAIC (Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica, Córdoba, Not set

Clinica Viedma, Viedma, Not set

Calvary Mater Newcastle Hospital, Waratah, New South Wales

Gallipoli Medical Research Foundation (Greenslopes Private Hospital), Greenslopes, Queensland

Linear Clinical Research, Nedlands, Western Australia

One Clinical Research - Nedlands, Nedlands, Western Australia

Austin Hospital, Heidelberg, Not set

Peter MacCallum Cancer Centre, North Melbourne, Not set

University of Sydney - Melanoma Institute Australia (MIA) - The Poche Centre, Wollstonecraft, Not set

The University of Queensland (UQ) - Princess Alexandra Hospital (PAH), Woolloongabba, Not set

LKH - Universitaetsklinikum Graz, Graz, Not set

Universitätsklinikum St. Pölten, Pölten, Not set

Paracelsus Medizinischen Privatuniversitaet - SALK - Universitaetsklinik fuer Dermatologie - EB-Haus Austria, Salzburg, Not set

Universite Libre de Bruxelles (ULB)-Institut Jules Bordet, Anderlecht, Not set

AZ Sint-Jan Brugge-Oostende AV-Campus Sint-Jan, Brugge, Not set

Universitair Ziekenhuis Brussel, Brussel, Not set

Cliniques Universitaires Saint-Luc - Institut Roi Albert II, Bruxelles, Not set

UZ Leuven, Leuven, Not set

Centro de Pesquisa Clinica em Oncologia - Oncosite, Ijuí, RS

Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa Ltda, Porto Alegre, RS

Fundacao Pio XII - Hospital de Cancer de Barretos - Hospital de Amor, Barretos, Not set

Hospital Sirio-Libanes (HSL) - Centro de Oncologia - Brasilia, Brasília, Not set

Centro de Pesquisas Oncologicas (CEPON), Florianópolis, Not set

Oncocentro Sao Carlos Hospital, Fortaleza, Not set

A.C.Camargo Cancer Center - Centro Internacional de Pesquisa (CIPE), Liberdade, Not set

Hospital de Clinicas de Porto Alegre (HCPA), Porto Alegre, Not set

Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS) - Hospital Sao Lucas - Centro de Pesquisa Clinica (CPC), Porto Alegre, Not set

National Cancer Institute, Rio De Janeiro, Not set

Instituto Américas - Instituto de Educação Pesquisa e Gestão em Saúde Oncosite, Rio De Janeiro, Not set

Instituto do Cancer do Estado de Sao Paulo (ICESP), São Paulo, Not set

Hospital 9 de Julho, São Paulo, Not set

Faculdade de Medicina de Sao Jose do Rio Preto-SP (FAMERP) - Hospital de Base (HB) - Centro Integrado de Pesquisa (CIP), São Paulo, Not set

Uni Hospital, Panagyurishte, Not set

Complex Oncology Center - Plovdiv Ltd., Plovdiv, Not set

University Hospital Tsaritsa Yoanna (ISUL) (Queen Giovanna University Hospital), Sofia, Not set

Regina Life Clinic, Sofia, Not set

Princess Margaret Cancer Centre, Toronto, Ontario

Cross Cancer Institute, Edmonton, Not set

Fakultni Nemocnice Hradec Kralove (FNHK) - Klinika Onkologie a Radioterapie, Hradec Králové, Not set

Fakultni Nemocnice Olomouc (FNOL), Olomouc, Not set

Sanatorium Profesora Arenbergera, Praha, Not set

Kobenhavns Universitet - Herlev Hospital (Amtssygehuset i Herlev), Herlev, Not set

Hôpital de la Timone, Marseille, Cedex

Oncopole Claudius Regaud- Institut Universitaire du Cancer de Toulouse, Toulouse, Cedex

Assistance Publique-Hopitaux de Paris (AP-HP) - Hopitaux Universitaires Paris Seine-Saint-Denis - Hopital Avicenne, Bobigny, Not set

Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Ambroise-Pare, Boulogne-Billancourt, Not set

UNICANCER-Centre Francois Baclesse (CFB), Caen, Not set

CHU de Dijon Bourgogne - Hôpital François Mitterrand, Dijon, Not set

Centre Hospitalier Universitaire de Lille (CHU Lille)-Hopital Claude Huriez, Lille, Not set

Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hotel-Dieu, Nantes, Not set

Hospital Saint Louis, Paris, Not set

Hospices Civils de Lyon (HCL) - Centre Hospitalier Lyon-Sud, Pierre-Benite, Not set

Centre Hospitalier Universitaire de Rouen (CHU de Rouen) - Hopital Charles-Nicolle, Rouen, Not set

Hopital Robert Debre, Valence, Not set

Institut Gustave Roussy (IGR) Service de Dermatolgie, Villejuif, Not set

Charite-Universitaetsmedizin Berlin - Campus Charite Mitte (CCM) - Klinik fuer Dermatologie Venerologie und Allergologie - Hauttumorcentrum Charite (HTCC), Berlin, Not set

Universitätsklinikum Carl Gustav Carus, Dresden, Not set

Helios Klinikum Erfurt - Klinik fuer Hautkrankheiten und Allergologie, Erfurt, Not set

Universitaetsklinikum Essen, Essen, Not set

Johann Wolfgang Goethe-Universitaet Frankfurt am Main - Klinik fuer Dermatologie, Venerologie und Allergologie, Frankfurt, Not set

Justus-Liebig-Universitaet Giessen - Klinik fuer Dermatologie und Andrologie, Gießen, Not set

University of Hamburg, Hamburg, Not set

Elbe Kliniken Stade - Hautkrebszentrum Buxtehude, Hamburg, Not set

Universitaetsklinikum Heidelberg (UKHD) - Hautklinik, Heidelberg, Not set

Universitaetsklinikum Leipzig - Klinik fuer Dermatologie, Venerologie und Allergologie, Leipzig, Not set

Johannes Wesling Klinikum Minden, Minden, Not set

LMU Klinikum - Klinik und Poliklinik fur Dermatologie und Allergologie, Munich, Not set

Universitaetsklinikum Tuebingen (UKT) - Zentrum fuer Dermatoonkologie - Hautklinik, Tübingen, Not set

Universitaetsklinikum Wuerzburg - Klinik und Poliklinik fuer Dermatologie Venerologie und Allergologie, Würzburg, Not set

Semmelweis Egyetem Általános Orvostudományi Kar, Budapest, Not set

Pecsi Tudomanyegyetem (PTE) (University of Pecs), Pécs, Not set

Szegedi Tudomanyegyetem (University of Szeged), Szeged, Not set

Istituto Tumori Giovanni Paolo II - Ospedale Oncologico di Bari, Bari, Not set

Humanitas Gavazzeni (Cliniche Gavazzeni S.p.A), Bergamo, Not set

IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" Srl (IRST), Meldola, Not set

Fondazione IRCCS - Istituto Nazionale dei Tumori - Milano, Milano, Not set

Istituto Europeo di Oncologia (IEO) (European Institute of Oncology), Milan, Not set

Istituto Nazionale Tumori (INT) "Fondazione G. Pascale" di Napoli, Napoli, Not set

Istituto Oncologico Veneto (IOV) IRCCS, Padova, Not set

Azienda Ospedaliera di Perugia - Ospedale Santa Maria della Misericordia, Perugia, Not set

Azienda Sanitaria Locale di Biella (ASL BI) - Ospedale degli Infermi, Ponderano, Not set

National Cancer Institute Regina Elena, Roma, Not set

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Not set

" Azienda Ospedaliera Universitaria Senese - Policlinico Santa Maria Alle Scotte - Clinica Immunoterapia Oncologica", Siena, Not set

Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino, Torino, Not set

Haukeland University Hospital, Bergen, Not set

Oslo University Hospital, Oslo, Not set

Centrum Onkologii im. Prof. Franciszka Łukaszczyka, Bydgoszcz, Not set

Klinika Onkologii i Radioterapii Uniwersyteckie Centrum Kliniczne, Gdansk, Not set

Centrum Medyczne Pratia Poznań - Skorzewo, Skorzewo, Not set

Klinika Nowotworów Tkanek Miękkich, Kości i Czerniaków, Warszawa, Not set

L'Institute Oncologique Prof. Dr. Ion Chiricuta (IOCN) (The Oncology Institute Prof. Dr. Ion. Chiricuta), Cluj-Napoca, Not set

Sf Nectarie Oncology Center, Craiova, Not set

Victoria Hospital (Centrul de oncologie Euroclinic SRL) (Centrul De Oncologie Medicala) (Euroclinic Onchology Center), Iaşi, Not set

Universidad de Cantabria (UC) - Hospital Universitario Marques de Valdecilla (HUMV), Santander, Cantabria

Universidad de Murcia - Hospital Universitario Virgen de la Arrixaca (HUVA), El Palmar, Murcia

Complejo Hospitalario Universitario A Coruna (CHUAC), A Coruña, Not set

Hospital Universitari Vall d'Hebron, Barcelona, Not set

Hospital Universitario Dexeus, Barcelona, Not set

Hospital Duran i Reynals, Barcelona, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

Hospital Universitario Reina Sofia, Córdoba, Not set

Hospital Universitario Virgen de las Nieves (HUVN), Granada, Not set

Hospital General Universitario Gregorio Marañon, Madrid, Not set

Universidad de Navarra - Clinica Universidad de Navarra (CUN) - Madrid, Madrid, Not set

Hospital Universitario Ramon y Cajal, Madrid, Not set

Universidad Complutense de Madrid (UCM)-Hospital Universitario 12 de Octubre (H12O), Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Centro Integral Oncologico Clara Campal (CIOCC), Madrid, Not set

Hospital Regional Universitario de Malaga, Málaga, Not set

Universidad de Navarra - Clinica Universidad de Navarra (CUN) - Pamplona, Pamplona, Not set

Hospital Universitario Virgen del Rocio, Sevilla, Not set

Hospital Universitario Virgen Macarena, Seville, Not set

Instituto de Investigacion Sanitaria (INCLIVA) (Institute of Health Research Hospital Clinic of Valencia), Valencia, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur), Valencia, Not set

Servicio Aragones de Salud - Hospital Universitario Miguel Servet (HUMS), Zaragoza, Not set

Sahlgrenska Akademin - Institutionen for Kliniska Vetenskaper (Institute of Clinical Sciences), Göteborg, Not set

Lanssjukhuset Ryhov - Onkologiska Kliniken, Jönköping, Not set

Skanes Universitetssjukhus - Lund - Onkologiska Klinik, Lund, Not set

Karolinska Universitetssjukhuset, Stockholm, Not set

Uppsala Universitet - Akademiska Sjukhuset (Uppsala University Hospital), Uppsala, Not set

UniversitaetsSpital Zuerich - Dermatologische Klinik, Zurich, Not set

Memorial Saglik Grubu - Memorial Ankara Hastanesi, Çankaya, Ankara

Medical Park Hastaneler Grubu - I.A.U. VM Medical Park Florya, Antalya, Campus

Medical Park Gaziantep Hastanesi, Şehitkamil, Gaziantep

Memorial Saglik Grubu - Memorial Bahcelievler Hastanesi, Bahçelievler, Istanbul

Ege Universitesi Tip Fakultesi (Ege University Faculty of Medicine), Bornova, İzmir

Izmir Ekonomi Universitesi Medikal Point Hastanesi, Karşıyaka, İzmir

Kanser Enstitusu (Hacettepe University Cancer Institute), Altındağ, Not set

T.C. Saglik Bakanligi - SBU Gulhane Egitim ve Arastirma Hastanesi, Ankara, Not set

Inonu Universitesi - Turgut Ozal Tip Merkezi, Malatya, Not set

Ondokuz Mayis Universitesi (OMU) - Tip Facultesi, Samsun, Not set

Medical Park Seyhan Hastanesi, Seyhan, Not set

T.C. Saglik Bakanligi - Ankara Etlik sehir Hastanesi, Yenimahalle, Not set

Ankara Bilkent City Hospital, Oncology Department, Çankaya, Not set

Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital (AH) - Oncology Centre, Cambridge, Not set

Beatson West of Scotland Cancer Centre, Glasgow, Not set

The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, Not set

Sarah Cannon Research Institute (SCRI) - London (SCRI-UK), London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Royal Marsden Hospital - Sutton, Surrey Quays, Not set

Conditions: Advanced Melanoma

Learn More ›

Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)

NCT06161116

Recruiting

The purpose of this study is to evaluate the efficacy and safety of MK-6194 in adult participants with Systemic Lupus Erythematosus. The primary hypothesis is that at least 1 of the MK-6194 arms is superior to placebo in the primary endpoint of percentage of participants with systemic lupus erythematosus responder index (SRI-4) response at Week 28.

Gender:

ALL

Ages:

Between 18 years and 75 years

Trial Updated:

07/23/2025

Locations: Medvin Clinical Research - Metyas ( Site 0128), Covina, California +126 locations

Medvin Clinical Research - Metyas ( Site 0128), Covina, California

UCSD - Altman Clinical and Translational Research Institute (ACTRI)-Center for Innovative Therapy ( Site 0110), La Jolla, California

Arthritis & Osteoporosis Medical Center - La Palma ( Site 0108), La Palma, California

Medvin Clinical Research - Tujunga ( Site 0127), Tujunga, California

Denver Arthritis Clinic ( Site 0102), Denver, Colorado

Clinical Research of West Florida, Inc. (Clearwater) ( Site 0111), Clearwater, Florida

IRIS Research and Development, LLC-Research ( Site 0117), Plantation, Florida

Clinical Research of West Florida, Inc ( Site 0124), Tampa, Florida

Morehouse School of Medicine ( Site 0146), Atlanta, Georgia

Accurate Clinical Research, Inc ( Site 0135), Lake Charles, Louisiana

AA Medical Research Center ( Site 0136), Grand Blanc, Michigan

Javara - Tryon Medical Partners ( Site 0121), Charlotte, North Carolina

DJL Clinical Research, PLLC ( Site 0103), Charlotte, North Carolina

University of Oklahoma Health Science Center ( Site 0130), Oklahoma City, Oklahoma

Shelby Research, LLC ( Site 0142), Memphis, Tennessee

Accurate Clinical Management, LLC. ( Site 0134), Baytown, Texas

Epic Medical Research ( Site 0113), DeSoto, Texas

Accurate Clinical Research, Inc. ( Site 0133), Houston, Texas

SouthWest Rheumatology Research, LLC ( Site 0115), Mesquite, Texas

Centro de Investigaciones Médicas Mar del Plata ( Site 0210), Mar del Plata, Buenos Aires

Sanatorio Parque ( Site 0205), Rosario, Santa Fe

Clínica de Nefrología, Urología y Enfermedades Cardiovasculares ( Site 0206), Santa Fe., Santa Fe

Centro de Investigaciones Médicas Tucuman ( Site 0203), SAN M. DE Tucuman, Tucuman

Instituto de Reumatología ( Site 0201), Mendoza, Not set

IPC - MT Instituto de Pesquisas Clínicas do Mato Grosso ( Site 0313), Cuiaba, Mato Grosso

Núcleo de Pesquisa Clínica do Rio Grande do Sul ( Site 0309), Porto Alegre, Rio Grande Do Sul

LMK Serviços Médicos S/S-Reumacenter ( Site 0303), Porto Alegre, Rio Grande Do Sul

Centro Multidisciplinar de Estudos Clinicos ( Site 0302), Sao Bernardo do Campo, Sao Paulo

Hospital de Base de São José do Rio Preto-CIP - Centro Integrado de Pesquisas ( Site 0311), São José do Rio Preto, Sao Paulo

Diex Recherche Sherbrooke ( Site 0003), Sherbrooke, Quebec

James Lind Centro de Investigacion del Cancer ( Site 0407), Temuco, Araucania

IC La Serena Research ( Site 0414), La Serena., Coquimbo

Clinica Dermacross ( Site 0416), Santiago., Region M. De Santiago

Centro Internacional de Estudios Clinicos (CIEC) ( Site 0410), Santiago., Region M. De Santiago

Complejo Asistencial Dr. Sotero del Rio ( Site 0402), Santiago, Region M. De Santiago

CECIM ( Site 0405), Santiago, Region M. De Santiago

The First Afflilated Hospital of Bengbu Medical College-Urology Surgery ( Site 2019), Bengbu, Anhui

Anhui Provincial Hospital ( Site 2043), Hefei, Anhui

Beijing Peking Union Medical College Hospital-Department of Rheumatology and Immunology ( Site 2001), Beijing, Beijing

Gansu Provincial Hospital ( Site 2065), Lanzhou, Gansu

Sun Yat-sen Memorial Hospital, Sun Yat-sen University ( Site 2036), Guangzhou, Guangdong

Southern Medical University Nanfang Hospital ( Site 2037), Guangzhou, Guangdong

The Affiliated Hospital of Guizhou Medical University ( Site 2051), Guiyang, Guizhou

The Second Afilliated Hospital of Hebei Medical University-Immunology And Rheumatology ( Site 2064), Shijiazhuang, Hebei

The First Affiliated Hospital of Henan University of Science &Technology ( Site 2041), Luoyang, Henan

Tongji Hospital Tongji Medical,Science & Technology ( Site 2042), Wuhan, Hubei

The First Affiliated Hospital of Nanhua University ( Site 2061), Hengyang, Hunan

The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Te ( Site 2006), Baotou, Inner Mongolia

Affiliated Hospital of Nantong University ( Site 2027), Nantong, Jiangsu

Pingxiang People's Hospital ( Site 2005), Pingxiang, Jiangxi

Jilin Province People's Hospital ( Site 2033), Chang chun, Jilin

The First Affiliated Hospital of Xi'an Jiaotong University ( Site 2056), Xi'an, Shaanxi

Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 2053), Shanghai, Shanghai

Shanxi Bethune Hospital ( Site 2029), Taiyuan, Shanxi

The First Affiliated Hospital Of Chengdu Medical College ( Site 2052), Chengdu, Sichuan

Tianjin Medical University General Hospital-Rheumatism and Immunology ( Site 2011), Tianjin, Tianjin

Salud SURA Industriales ( Site 0508), Medellín, Antioquia

Centro Integral de Reumatología del Caribe ( Site 0501), Barranquilla, Atlantico

Clinica de la Costa S.A.S. ( Site 0502), Barranquilla, Atlantico

Preventive Care ( Site 0507), Chía, Cundinamarca

Healthy Medical Center S.A.S ( Site 0505), Zipaquira, Cundinamarca

Fundación Valle del Lili ( Site 0506), Cali, Valle Del Cauca

Centro de Estudios de Reumatología y Dermatología SAS ( Site 0512), Cali, Valle Del Cauca

CHU Bordeaux Haut-Leveque ( Site 1007), Pessac, Aquitaine

CHU Rangueil ( Site 1008), Toulouse, Haute-Garonne

CHU Montpellier Lapeyronie Hospital-Rhumatologie ( Site 1006), Montpellier, Herault

Centre Hospitalier Universitaire de Saint Étienne - Hôpital Nord ( Site 1009), Saint Priest En Jarez, Loire

Hopital Claude Huriez - CHU de Lille ( Site 1005), Lille, Nord

Centre Hospitalier Saint Joseph - Saint Luc ( Site 1003), Lyon, Rhone-Alpes

Clinica Medica Especializada en Medicina Interna y Reumatología ( Site 0601), Ciudad de Guatemala, Not set

Clínica Médica Especializada en Pediatría e Infectología Pediátrica - Dr. Mario Melgar ( Site 0602), Guatemala, Not set

CELAN,S.A ( Site 0603), Guatemala, Not set

Istituto Clinico Humanitas Research Hospital ( Site 1310), Rozzano, Milano

Fondazione Policlinico Universitario Campus Bio-Medico ( Site 1307), Rome, Roma

Azienda Ospedaliero Universitaria Senese-Medicina Interna e Specialistica ( Site 1306), Siena, Toscana

Azienda Ospedale - Università Padova-Department of Medicine-DIMED ( Site 1309), Padova, Veneto

AOU Careggi ( Site 1311), Firenze, Not set

Azienda Ospedaliera Universitaria dell'Università "Luigi Van-UNITA'OPERATIVA DI REUMATOLOGIA, DIPAR ( Site 1305), Napoli, Not set

Fondazione Policlinico Universitario Agostino Gemelli IRCCS -UOC Reumatologia ( Site 1304), Roma, Not set

Japan Community Healthcare Organization Chukyo Hospital ( Site 2107), Nagoya, Aichi

St. Marianna University Hospital ( Site 2121), Kawasaki, Kanagawa

Tohoku University Hospital ( Site 2116), Sendai-shi, Miyagi

Yuuai Medical Center ( Site 2122), Tomigusuku, Okinawa

Shimane University Hospital ( Site 2119), Izumo, Shimane

Dokkyo Medical University Hospital ( Site 2118), Shimotsuga, Tochigi

Nihon University Itabashi Hospital ( Site 2105), Itabashiku, Tokyo

Showa Medical University East Hospital ( Site 2123), Shinagawa, Tokyo

Chiba University Hospital ( Site 2120), Chiba, Not set

NHO Chiba Medical Center Chibahigashi National Hospital ( Site 2112), Chiba, Not set

Okayama University Hospital ( Site 2106), Okayama, Not set

Osaka Keisatsu Hospital ( Site 2117), Osaka, Not set

Hospital Canselor Tuanku Muhriz UKM ( Site 2225), Cheras, Kuala Lumpur

University Malaya Medical Centre-Clinical Investigation Centre (CIC) ( Site 2222), Lembah Pantai, Kuala Lumpur

Hospital Tengku Ampuan Afzan-Medical Outpatient Department ( Site 2224), Kuantan, Pahang

Hospital Taiping ( Site 2221), Taiping, Perak

RM Pharma Specialists ( Site 0711), Mexico City, Distrito Federal

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0713), Mexico City, Distrito Federal

Morales Vargas Centro de Investigacion ( Site 0710), León, Guanajuato

Centro Integral en Reumatologia ( Site 0701), Guadalajara, Jalisco

Centro de Atención en Enfermedades Inflamatorias CATEI ( Site 0707), Guadalajara, Jalisco

Clinica de Investigacion en Reumatologia y Obesidad S. C. ( Site 0705), Guadalajara, Jalisco

Centro de Estudios de Investigacion Basica y Clinica ( Site 0708), Guadalajara, Jalisco

Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Rheumatology ( Site 0706), Monterrey, Nuevo Leon

Centro Potosino de Investigación Médica ( Site 0703), San Luis Potosí, San Luis Potosi

Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan ( Site 0712), Merida, Yucatan

ICARO Investigaciones en Medicina ( Site 0702), Chihuahua, Not set

Clinstile, S.A. de C.V. ( Site 0709), Distrito Federal, Not set

Mary Mediatrix Medical Center ( Site 2303), Lipa City, Batangas

ST. LUKE'S MEDICAL CENTER ( Site 2304), Quezon City, National Capital Region

Iloilo Doctors' Hospital ( Site 2301), Iloilo, Not set

MICS Centrum Medyczne Bydgoszcz ( Site 1410), Bydgoszcz, Kujawsko-pomorskie

Zespół Poradni Specjalistycznych Reumed Filia nr 1 Wallenroda ( Site 1408), Lublin, Lubelskie

Centrum Medyczne Plejady ( Site 1407), Krakow, Malopolskie

MICS Centrum Medyczne Warszawa ( Site 1411), Warszawa, Mazowieckie

Nova Reuma Społka Partnerska ( Site 1405), Bialystok, Podlaskie

NZOZ BIF-MED ( Site 1409), Bytom, Slaskie

Medyczne Centrum Hetmańska ( Site 1406), Poznan, Wielkopolskie

Prywatna Praktyka Lekarska Prof. UM dr hab. med. Pawel Hrycaj ( Site 1402), Poznan, Wielkopolskie

CHUAC-Complejo Hospitalario Universitario A Coruña-Reumatologia ( Site 1604), A Coruña, La Coruna

HOSPITAL CLINICO DE VALENCIA ( Site 1608), Valencia, Valenciana, Comunitat

Hospital Universitari Vall d'Hebron-Rheumatology ( Site 1601), Barcelona, Not set

Hospital Quiron Infanta Luisa-Unidad de investigacion de Reumatologia ( Site 1602), Sevilla, Not set

Hospital Universitario Rio Hortega ( Site 1606), Valladolid, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi ( Site 1709), Kadikoy, Istanbul

ANKARA UNIVERSITY IBNI SINA HOSPITAL-Rheumatology Department ( Site 1703), Ankara, Not set

Ankara Bilkent Şehir Hastanesi-Rheumatology ( Site 1702), Ankara, Not set

Sakarya Training and Research Hospital-Rheumatology ( Site 1708), Sakarya, Not set

Conditions: Systemic Lupus Erythematosus

Learn More ›

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

NCT06467357

Recruiting

The purpose of this study is to measure the efficacy and safety of T-DXd with rilvegostomig or T-DXd monotherapy compared with gemcitabine plus cisplatin and durvalumab in patients with advanced treatment naïve HER2-expressing BTC.

Gender:

ALL

Ages:

Between 18 years and 99 years

Trial Updated:

07/23/2025

Locations: Research Site, Scottsdale, Arizona +253 locations

Research Site, Scottsdale, Arizona

Research Site, Tucson, Arizona

Research Site, Fullerton, California

Research Site, La Jolla, California

Research Site, Los Alamitos, California

Research Site, Los Angeles, California

Research Site, San Francisco, California

Research Site, Fort Myers, Florida

Research Site, Jacksonville, Florida

Research Site, Saint Petersburg, Florida

Research Site, Tampa, Florida

Research Site, West Palm Beach, Florida

Research Site, Atlanta, Georgia

Research Site, Coeur d'Alene, Idaho

Research Site, Chicago, Illinois

Research Site, Niles, Illinois

Research Site, Towson, Maryland

Research Site, Worcester, Massachusetts

Research Site, Detroit, Michigan

Research Site, Grand Rapids, Michigan

Research Site, Rochester, Minnesota

Research Site, Kansas City, Missouri

Research Site, Saint Louis, Missouri

Research Site, Albuquerque, New Mexico

Research Site, New York, New York

Research Site, Cleveland, Ohio

Research Site, Columbus, Ohio

Research Site, Greenville, South Carolina

Research Site, Nashville, Tennessee

Research Site, Austin, Texas

Research Site, Dallas, Texas

Research Site, Fort Worth, Texas

Research Site, Houston, Texas

Research Site, Pearland, Texas

Research Site, San Antonio, Texas

Research Site, Fairfax, Virginia

Research Site, Chermside, Not set

Research Site, Clayton, Not set

Research Site, Concord, Not set

Research Site, Nedlands, Not set

Research Site, Graz, Not set

Research Site, Linz, Not set

Research Site, Salzburg, Not set

Research Site, Wiener Neustadt, Not set

Research Site, Wien, Not set

Research Site, Anderlecht, Not set

Research Site, Edegem, Not set

Research Site, Gent, Not set

Research Site, Leuven, Not set

Research Site, Liège, Not set

Research Site, Roeselare, Not set

Research Site, Natal, Not set

Research Site, Porto Alegre, Not set

Research Site, Santa Maria, Not set

Research Site, Sao Paulo, Not set

Research Site, São Paulo, Not set

Research Site, Vitória, Not set

Research Site, Edmonton, Alberta

Research Site, Halifax, Nova Scotia

Research Site, Brampton, Ontario

Research Site, Toronto, Ontario

Research Site, Montréal, Quebec

Research Site, Beijing, Not set

Research Site, Bengbu, Not set

Research Site, Changchun, Not set

Research Site, Changde, Not set

Research Site, Changsha, Not set

Research Site, Chengdu, Not set

Research Site, Chongqing, Not set

Research Site, Fuzhou, Not set

Research Site, Guangzhou, Not set

Research Site, Guiyang, Not set

Research Site, Hangzhou, Not set

Research Site, Harbin, Not set

Research Site, Hefei, Not set

Research Site, Jinan, Not set

Research Site, Kunming, Not set

Research Site, Luoyang, Not set

Research Site, Nanchang, Not set

Research Site, Nanning, Not set

Research Site, Nantong, Not set

Research Site, Shanghai, Not set

Research Site, Shenyang, Not set

Research Site, Shenzhen, Not set

Research Site, Tianjin, Not set

Research Site, Wuhan, Not set

Research Site, Xi'an, Not set

Research Site, Zhengzhou, Not set

Research Site, Brno, Not set

Research Site, Hradec Kralove, Not set

Research Site, Olomouc, Not set

Research Site, Praha 10, Not set

Research Site, Praha 5, Not set

Research Site, Brest, Not set

Research Site, Clichy Cedex, Not set

Research Site, Dijon, Not set

Research Site, Lille, Not set

Research Site, Lyon, Not set

Research Site, Marseille, Not set

Research Site, Montpellier, Not set

Research Site, Nimes, Not set

Research Site, Pessac, Not set

Research Site, Villejuif, Not set

Research Site, Berlin, Not set

Research Site, Bonn, Not set

Research Site, Dresden, Not set

Research Site, Frankfurt, Not set

Research Site, Freiburg, Not set

Research Site, Göttingen, Not set

Research Site, Hamburg, Not set

Research Site, Köln, Not set

Research Site, Leipzig, Not set

Research Site, Lübeck, Not set

Research Site, Munchen, Not set

Research Site, Ulm, Not set

Research Site, Würzburg, Not set

Research Site, Hong Kong, Not set

Research Site, Shatin, Not set

Research Site, Dehradun, Not set

Research Site, Delhi, Not set

Research Site, Kolkata, Not set

Research Site, Mumbai, Not set

Research Site, Vadodara, Not set

Research Site, Varanasi, Not set

Research Site, Firenze, Not set

Research Site, Milano, Not set

Research Site, Naples, Not set

Research Site, Napoli, Not set

Research Site, Padova, Not set

Research Site, Roma, Not set

Research Site, Rozzano, Not set

Research Site, Tricase, Not set

Research Site, Bunkyo-ku, Not set

Research Site, Chiba-shi, Not set

Research Site, Fukuyama-shi, Not set

Research Site, Hirakata-shi, Not set

Research Site, Hiroshima-shi, Not set

Research Site, Kanazawa, Not set

Research Site, Kashiwa, Not set

Research Site, Kawasaki-shi, Not set

Research Site, Kita-gun, Not set

Research Site, Kitaadachi-gun, Not set

Research Site, Koto-ku, Not set

Research Site, Kumamoto-shi, Not set

Research Site, Kyoto-shi, Not set

Research Site, Maebashi-shi, Not set

Research Site, Mitaka-shi, Not set

Research Site, Nagoya-shi, Not set

Research Site, Osaka-shi, Not set

Research Site, Osaka, Not set

Research Site, Sakai-shi, Not set

Research Site, Sapporo-shi, Not set

Research Site, Sendai-shi, Not set

Research Site, Shinjuku-ku, Not set

Research Site, Suita-city, Not set

Research Site, Sunto-gun, Not set

Research Site, Ube-shi, Not set

Research Site, Wakayama-shi, Not set

Research Site, Yokohama-shi, Not set

Research Site, Busan, Not set

Research Site, Gyeonggi-do, Not set

Research Site, Hwasun-gun, Not set

Research Site, Seongnam-si, Not set

Research Site, Seoul, Not set

Research Site, George Town, Not set

Research Site, Johor Bahru, Not set

Research Site, Kuala Lumpur, Not set

Research Site, Kuching, Not set

Research Site, Rotterdam, Not set

Research Site, Cebu City, Not set

Research Site, Makati, Not set

Research Site, Pasig City, Not set

Research Site, Quezon City, Not set

Research Site, Białystok, Not set

Research Site, Katowice, Not set

Research Site, Kraków, Not set

Research Site, Lublin, Not set

Research Site, Warszawa, Not set

Research Site, Wrocław, Not set

Research Site, Ar Riyāḑ, Not set

Research Site, Dammam, Not set

Research Site, Riyadh, Not set

Research Site, Banska Bystrica, Not set

Research Site, Bratislava, Not set

Research Site, Kosice, Not set

Research Site, Martin, Not set

Research Site, Trnava, Not set

Research Site, Barcelona, Not set

Research Site, Madrid, Not set

Research Site, Málaga, Not set

Research Site, Santander, Not set

Research Site, Kaohsiung City, Not set

Research Site, Kaohsiung, Not set

Research Site, Taichung, Not set

Research Site, Taipei 112, Not set

Research Site, Taipei, Not set

Research Site, Taoyuan, Not set

Research Site, Bangkok, Not set

Research Site, Hat Yai, Not set

Research Site, Khon Kaen, Not set

Research Site, Muang, Not set

Research Site, Mueang, Not set

Research Site, Naimuang, Not set

Research Site, Ongkharak, Not set

Research Site, Sisaket, Not set

Research Site, Altındağ, Not set

Research Site, Antalya, Not set

Research Site, Istanbul, Not set

Research Site, Izmir, Not set

Research Site, Mezitli, Not set

Research Site, Yakutiye, Not set

Research Site, Birmingham, Not set

Research Site, Dundee, Not set

Research Site, Glasgow, Not set

Research Site, Greater London, Not set

Research Site, Leeds, Not set

Research Site, London, Not set

Research Site, Hanoi, Not set

Research Site, Ho Chi Minh city, Not set

Research Site, Ho Chi Minh City, Not set

Research Site, Ho Chi Minh, Not set

Research Site, Vinh, Not set

Conditions: Biliary Tract Cancer

Learn More ›

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

NCT06384261

Recruiting

The goal of this clinical trial is to learn if participants treated with the experimental drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to venetoclax and azacitidine. Venetoclax and azacitidine are drugs commonly used to treat AML in patients that are unable to receive chemotherapy to treat AML. The main question the clinical trial aims to answer is does cusatuzumab added to venetoclax and azacitidine prolong the length of time particip... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/23/2025

Locations: Banner MD Anderson, Gilbert, Arizona +30 locations

Banner MD Anderson, Gilbert, Arizona

City of Hope, Duarte, California

University of California Los Angeles, Los Angeles, California

University of Colorado Health - Anschutz Cancer Pavilion - Anschutz Medical Campus, Aurora, Colorado

Yale School of Medicine, New Haven, Connecticut

AdventHealth Medical Group Blood & Marrow Transplant at Orlando, Orlando, Florida

The University of Iowa Hospitals & Clinics, Iowa City, Iowa

University of Kentucky Chandler Medical Center, Lexington, Kentucky

Norton Healthcare, Inc., Louisville, Kentucky

Hackensack University Medical Center, Hackensack, New Jersey

Hofstra/Northwell Health, Lake Success, New York

Cornell University, New York, New York

University of Rochester Medical Center, Rochester, New York

Wake Forest North Carolina, Winston-Salem, North Carolina

Medical University of South Carolina, Charleston, South Carolina

Fred Hutch Seattle Cancer Care Alliance, Seattle, Washington

Medical College of Wisonsin, Milwaukee, Wisconsin

Tom Baker Cancer Center-Alberta Health Services - University of Calgary, Calgary, Alberta

Stollery Children's Hospital-Walter C Mackenzie Health Sciences Centre - University of Alberta, Edmonton, Alberta

Vancouver General Hospital, Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia

University of Western Ontario, London, Ontario

The Ottawa Hospital - General Campus, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Saskatchewan Cancer Agency - Saskatoon Cancer Centre, Saskatoon, Saskatchewan

Marien Hospital Duesseldorf, Dusseldorf, Not set

Universitaetsklinik Frankfurt, Frankfurt, Not set

Medizinische Hochschule Hanover, Hannover Medical School, Hannover, Not set

Universitaetsklinik um Schleswig-Holstein, UKSH-Campus Kiel, Kiel, Not set

Inselspital Bern, Bern, Not set

HFR Fribourg - Hopital Cantonal, Fribourg, Not set

Kantonsspital St. Gallen, Saint Gallen, Not set

Conditions: Leukemia, Myeloid, Acute

Learn More ›

A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

NCT06721156

Recruiting

Researchers want to learn if giving MK-1167 (the study medicine) along with acetylcholinesterase inhibitor (AChEI) therapy can improve symptoms of Alzheimer's disease dementia (AD dementia), such as memory and mental activity. AD dementia is the most common type of dementia. AChEI therapy is the standard treatment for AD dementia. The goals of this study are to learn: * If at least one dose level (amount) of MK-1167 works to improve a person's memory and thinking compared to a placebo * About... Read More

Gender:

ALL

Ages:

Between 55 years and 90 years

Trial Updated:

07/23/2025

Locations: Banner Alzheimer's Institute ( Site 0110), Phoenix, Arizona +67 locations

Banner Alzheimer's Institute ( Site 0110), Phoenix, Arizona

Irvine Clinical Research ( Site 0104), Irvine, California

Anderson Clinical Research ( Site 0164), Redlands, California

California Neuroscience Research ( Site 0118), Sherman Oaks, California

JEM Research Institute / Headlands Research Network ( Site 0108), Atlantis, Florida

Brain Matters Research-Neurology ( Site 0150), Delray Beach, Florida

Neuropsychiatric Research Center of Southwest Florida ( Site 0152), Fort Myers, Florida

Indago Research & Health Center, Inc ( Site 0128), Hialeah, Florida

K2 Medical Research THE VILLAGES ( Site 0166), Lady Lake, Florida

K2 Medical Research ( Site 0103), Maitland, Florida

Premier Clinical Research Institute ( Site 0114), Miami, Florida

Aqualane Clinical Research ( Site 0116), Naples, Florida

Headlands Research Orlando ( Site 0169), Orlando, Florida

Brain Matters Research ( Site 0151), Stuart, Florida

K2 Medical Research Tampa LLC ( Site 0165), Tampa, Florida

Columbus Memory Center ( Site 0197), Columbus, Georgia

CenExel iResearch, LLC ( Site 0134), Savannah, Georgia

Tandem Clinical Research ( Site 0101), Marrero, Louisiana

Pharmasite Research, Inc. ( Site 0167), Baltimore, Maryland

Quest Research Institute ( Site 0173), Farmington Hills, Michigan

Velocity Clinical Research, Syracuse ( Site 0125), East Syracuse, New York

Mid Hudson Medical Research ( Site 0191), New Windsor, New York

Flourish Research - Charlotte ( Site 0106), Matthews, North Carolina

Velocity Clinical Research - Raleigh ( Site 0123), Raleigh, North Carolina

Summit Research Network ( Site 0111), Portland, Oregon

Kerwin Medical Center ( Site 0159), Dallas, Texas

Grayline Research Center ( Site 0105), Wichita Falls, Texas

Northwest Clinical Research Center ( Site 0102), Bellevue, Washington

IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas ( Site 0204), Ciudad Autonoma de Buenos Aires, Caba

Hospital Italiano de Buenos Aires ( Site 0209), Ciudad Autonoma de Buenos Aires, Caba

Instituto Geriatrico Nuestra Señora de Las Nieves ( Site 0208), Ciudad Autonoma de Buenos Aires, Caba

Okanagan Clinical Trials ( Site 0001), Kelowna, British Columbia

Ottawa Memory Clinic ( Site 0004), Ottawa, Ontario

Toronto Memory Program ( Site 0006), Toronto, Ontario

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico-UOSD Malattie Neurodegenerative ( Site 0903), Milano, Lombardia

Fondazione IRCCS San Gerardo dei Tintori ( Site 0902), Monza, Monza E Brianza

Centro S Giovanni Di Dio Fatebenefratelli ( Site 0904), Brescia, Not set

Ospedale San Raffaele. ( Site 0901), Milano, Not set

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 0905), Roma, Not set

Association of Healthcare Corporation Koukankai Koukan Clinic ( Site 1510), Kawasaki, Kanagawa

Kawasaki Saiwai Clinic ( Site 1501), Kawasaki, Kanagawa

Hatsuta Neurology Clinic ( Site 1507), Hirakata, Osaka

Nagomi Clinic ( Site 1506), Toyonaka, Osaka

Takesato Hospital ( Site 1522), Kasukabe, Saitama

Iwaki Clinic ( Site 1518), Anan, Tokushima

Enomoto Internal Medicine Clinic(Chofu) ( Site 1503), Chofu, Tokyo

Tokyo Metropolitan Institute for Geriatrics and Gerontology ( Site 1515), Itabashi, Tokyo

Nozomi Memory Clinic ( Site 1504), Mitaka, Tokyo

Itsuki Hospital ( Site 1502), Tokushima, Not set

Inha University Hospital ( Site 1601), Incheon, Not set

Seoul National University Hospital ( Site 1604), Seoul, Not set

Hanyang University Seoul Hospital ( Site 1605), Seoul, Not set

Asan Medical Center ( Site 1603), Seoul, Not set

Brain Research Center Den Bosch B.V. ( Site 1002), Den Bosch, Noord-Brabant

Brain Research Center. ( Site 1001), Amsterdam, Noord-Holland

Brain Research Center Zwolle ( Site 1003), Zwolle, Overijssel

Centro de Atención Especializada Oroitu ( Site 1211), Algorta, Bizkaia

Hospital de la Santa Creu i Sant Pau ( Site 1204), Barcelona, Cataluna

Hospital Universitario 12 de Octubre ( Site 1208), Madrid, Madrid, Comunidad De

Hospital Universitari i Politecnic La Fe ( Site 1202), València, Valencia

Fundació ACE ( Site 1206), Barcelona, Not set

Hospital Universitari Vall D Hebron ( Site 1203), Barcelona, Not set

Hospital Universitario Virgen de la Macarena ( Site 1210), Sevilla, Not set

Brain Sciences Scotland Life Sciences-Aberdeen ( Site 1402), Aberdeen, Aberdeen City

Scottish Brain Sciences ( Site 1401), Edinburgh, Edinburgh, City Of

Moorgreen Hospital ( Site 1409), Southampton, Hampshire

Remind UK ( Site 1404), Bath, Somerset

Re:Cognition Health - Birmingham ( Site 1406), Birmingham, Not set

Conditions: Alzheimer Disease, Dementia

Learn More ›

A Study Evaluating APG777 in Atopic Dermatitis

NCT06395948

Recruiting

This is a two-part study that will evaluate the safety and efficacy of APG777 in participants with moderate-to-severe Atopic Dermatitis (AD). Part A (Proof-of-concept) and Part B (Dose-regimen Finding) will evaluate the safety and efficacy of various induction and maintenance dose regimens of APG777 compared to placebo. The study duration for any individual participant will be up to 106 weeks which includes: screening, induction, maintenance, and post-treatment follow-up periods. Participants ra... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/23/2025

Locations: Investigational Site #14, Fountain Valley, California +87 locations

Investigational Site #14, Fountain Valley, California

Investigational Site # 46, Los Angeles, California

Investigational Site # 8, San Diego, California

Investigational Site # 44, New Haven, Connecticut

Investigational Site # 1, Coral Gables, Florida

Investigational site #48, Jacksonville, Florida

Investigational Site # 21, Margate, Florida

Investigational site #47, Douglasville, Georgia

Investigational site #88, Chicago, Illinois

Investigational Site # 36, Skokie, Illinois

Investigational Site # 38, West Lafayette, Indiana

Investigational site #50, Bowling Green, Kentucky

Investigational Site # 2, Rockville, Maryland

Investigational Site # 43, Detroit, Michigan

Investigational Site #10, Troy, Michigan

Investigational Site #16, Portsmouth, New Hampshire

Investigational site #49, New York, New York

Investigational Site # 3, Wilmington, North Carolina

Investigational Site # 31, Boardman, Ohio

Investigational Site #12, Mason, Ohio

Investigational Site #22, Portland, Oregon

Investigational Site # 34, Pittsburgh, Pennsylvania

Investigational Site # 37, Charleston, South Carolina

Investigational Site # 4, Nashville, Tennessee

Investigational Site # 23, Dallas, Texas

Investigational Site # 33, Dallas, Texas

Investigational Site # 18, San Antonio, Texas

Investigational Site # 5, Norfolk, Virginia

Investigational Site # 7, Mill Creek, Washington

Investigational Site # 26, Calgary, Alberta

Investigational Site #51, Calgary, Alberta

Investigational Site # 32, Edmonton, Alberta

Investigational site #73, Vancouver, British Columbia

Investigational Site #19, Winnipeg, Manitoba

Investigational Site #15, Fredericton, New Brunswick

Investigational site #52, Ajax, Ontario

Investigational Site # 9, Markham, Ontario

Investigational Site # 25, Mississauga, Ontario

Investigational site #53, Ottawa, Ontario

Investigational Site #13, Peterborough, Ontario

Investigational Site # 20, Toronto, Ontario

Investigational Site # 24, Toronto, Ontario

Investigational Site #11, Toronto, Ontario

Investigational Site # 6, Montreal, Quebec

Investigational Site #17, Québec, Quebec

Investigational site #85, Prague 5, Not set

Investigational site #54, Prague, Not set

Investigational site #81, Prague, Not set

Investigational site #59, Prague, Not set

Investigational site #57, Prague, Not set

Investigational site #80, Rouen, Normandie

Investigational site #86, Martigues, Not set

Investigational site #83, Nantes, Not set

Investigational site #82, Heidelberg, Baden-Wurttemberg

Investigational site #63, Tuebingen, Baden-Württemberg

Investigational site #76, Augsburg, Bavaria

Investigational site #62, München, Bayern

Investigational site #58, Blankenfelde-Mahlow, Brandenburg

Investigational site #61, Darmstadt, Hessen

Investigational site #65, Frankfurt, Hesse

Investigational site #74, Bad Bentheim, Lower Saxony

Investigational site #79, Münster, North Rhine Westfalia

Investigational site #78, Dresden, Saxony

Investigational site #75, Kiel, Schleswig-Holstein

Investigational site #64, Luebeck, Schleswig-Holstein

Investigational site #60, Berlin, Not set

Investigational site #55, Hamburg, Not set

Investigational site #72, Debrecen, Hajdú-Bihar

Investigational Site # 35, Wrocław, Dolnoslaskie

Investigational Site # 39, Wrocław, Dolnoslaskie

Investigational Site # 40, Lublin, Lubelskie

Investigational Site # 42, Warsaw, Mazowieckie

Investigational Site # 27, Warszawa, Mazowieckie

Investigational Site # 41, Gdańsk, Pomorskie

Investigational Site # 28, Katowice, Silesia

Investigational Site # 29, Sosnowiec, Silesia

Investigational Site # 30, Kraków, Woj. Małopolskie

Investigational site #56, Szczecin, Zachodniopomorskie

Investigational Site # 45, Łódź, Łódzkie

Investigational site #66, Santiago De Compostela, A Coruña

Investigational site #71, Badalona, Barcelona

Investigational site #68, Las Palmas De Gran Canaria, Islas Canarias

Investigational site #70, Alicante, Not set

Investigational site #84, Barcelona, Not set

Investigational site #69, Madrid, Not set

Investigational site #67, Madrid, Not set

Investigational site #77, Zaragoza, Not set

Investigational site #87, Dudley, West Midlands

Conditions: Atopic Dermatitis

Learn More ›

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants

NCT06115967

Recruiting

This study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses of AZD6912 administered subcutaneously (SC) in healthy participants.

Gender:

ALL

Ages:

Between 18 years and 50 years

Trial Updated:

07/23/2025

Locations: Research Site, Montréal, Quebec +1 locations

Conditions: Rheumatoid Arthritis

Learn More ›

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada

NCT07095192

Recruiting

The SCALE-POCT study is a national initiative designed to provide robust evidence for scaling up point-of-care hepatitis C testing for key populations. The study seeks to map current hepatitis C clinical processes, identify barriers and facilitators to implementation, and co-design practical tools and strategies in partnership with stakeholders. A major obstacle to hepatitis C elimination and increasing treatment uptake is the current multi-step diagnostic process, which leads to loss to follow... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/23/2025

Locations: Anonyme L'Unite D'Intervention, Montreal, Quebec +11 locations

Conditions: HCV, HEPATITIS C VIRUS CHRONIC INFECTION

Learn More ›

Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression

NCT07094789

Recruiting

The goal of this clinical trial is to evaluate the safety and initial effectiveness of Magnetic Resonance-guided focused ultrasound neuromodulation using the Next Generation Dome Helmet (NGDH) device in patients with treatment-resistant depression. This is a prospective, single-arm, non-randomized study. Participants will: * Undergo two focused ultrasound treatment sessions targeting nodes of the cortical-striatal-thalamic circuit (CSTC) , spaced four weeks apart. * Return for follow-up visits... Read More

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

07/23/2025

Locations: Sunnybrook Health Sciences Centre, Toronto, Ontario

Conditions: Treatment-Resistant Depression, Treatment-resistant Depression (TRD)

Learn More ›

Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP

NCT06079359

Recruiting

The primary purpose of this study is to evaluate the efficacy of ALXN1850 versus placebo on radiographic outcomes in pediatric participants with HPP who have not previously been treated with asfotase alfa.

Gender:

ALL

Ages:

Between 2 years and 11 years

Trial Updated:

07/23/2025

Locations: Research Site, Baltimore, Maryland +69 locations

Research Site, Baltimore, Maryland

Research Site, Kansas City, Missouri

Research Site, Durham, North Carolina

Research Site, Buenos Aires, Not set

Research Site, Ciudad de Buenos Aires, Not set

Research Site, Mar del Plata, Not set

Research Site, Nedlands, Not set

Research Site, Parkville, Not set

Research Site, Westmead, Not set

Research Site, Brussel, Not set

Research Site, Brasília, Not set

Research Site, Porto Alegre, Not set

Research Site, Recife, Not set

Research Site, Salvador, Not set

Research Site, São Paulo, Not set

Research Site, Calgary, Alberta

Research Site, Edmonton, Alberta

Research Site, Winnepeg, Manitoba

Research Site, Ottawa, Ontario

Research Site, Beijing, Not set

Research Site, Guangzhou, Not set

Research Site, Shanghai, Not set

Research Site, Shenzhen, Not set

Research Site, Helsinki, Not set

Research Site, Le Kremlin-Bicêtre, Not set

Research Site, Paris, Not set

Research Site, Homburg, Not set

Research Site, Ashkelon, Not set

Research Site, Beer Sheva, Not set

Research Site, Petah-Tikva, Not set

Research Site, Ramat Gan, Not set

Research Site, Bologna, Not set

Research Site, Genova, Not set

Research Site, Milano, Not set

Research Site, Roma, Not set

Research Site, Rome, Not set

Research Site, Seoul, Not set

Research Site, Campeche, Not set

Research Site, Chihuahua, Not set

Research Site, Ciudad de Mexico, Not set

Research Site, Zapopan, Not set

Research Site, Kraków, Not set

Research Site, Warszawa, Not set

Research Site, Łódź, Not set

Research Site, Bucureşti, Not set

Research Site, Madrid, Not set

Research Site, Vitoria, Not set

Research Site, Stockholm, Not set

Research Site, Taipei, Not set

Research Site, Taoyuan, Not set

Research Site, Bangkok, Not set

Research Site, Chaingmai, Not set

Research Site, Hat Yai, Not set

Research Site, Muang, Not set

Research Site, Ratchathewi, Not set

Research Site, Songkla, Not set

Research Site, Ankara, Not set

Research Site, Bursa, Not set

Research Site, Edirne, Not set

Research Site, Erzurum, Not set

Research Site, Istambul, Not set

Research Site, Birmingham, Not set

Research Site, Manchester, Not set

Research Site, Hanoi, Not set

Conditions: Hypophosphatasia

Learn More ›

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

NCT06136559

Recruiting

The goal of this study is to evaluate nemtabrutinib compared with investigator's choice of ibrutinib or acalabrutinib in participants with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who have not received any prior therapy. The primary hypotheses are that (1) nemtabrutinib is non-inferior to ibrutinib or acalabrutinib with respect to objective response rate (ORR) per International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Criteria 2018 by blinded independent centra... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/23/2025

Locations: USA Mitchell Cancer Institute ( Site 0014), Mobile, Alabama +181 locations

USA Mitchell Cancer Institute ( Site 0014), Mobile, Alabama

Arizona Oncology Associates - NAHOA ( Site 8007), Prescott, Arizona

Alta Bates Summit Medical Center ( Site 0004), Berkeley, California

Moores Cancer Center ( Site 0003), La Jolla, California

Saint Joseph Hospital ( Site 0026), Denver, Colorado

Lutheran Medical Center ( Site 0027), Golden, Colorado

Intermountain Health St. Mary's Regional Hospital ( Site 0025), Grand Junction, Colorado

Eastern CT Hematology & Oncology Associates ( Site 0033), Norwich, Connecticut

Clermont Oncology Center ( Site 0046), Clermont, Florida

Florida Cancer Specialists - South ( Site 7001), Fort Myers, Florida

Florida Cancer Specialists - East ( Site 7002), West Palm Beach, Florida

Parkview Research Center at Parkview Regional Medical Center ( Site 0002), Fort Wayne, Indiana

University of Iowa-Holden Comprehensive Cancer Center ( Site 0017), Iowa City, Iowa

Saint Elizabeth Healthcare ( Site 0041), Edgewood, Kentucky

Corewell Health-Lemmon Holton Cancer Pavilion ( Site 0011), Grand Rapids, Michigan

Regions Hospital ( Site 0042), Saint Louis Park, Minnesota

MidAmerica Cancer Care, LLC ( Site 0043), Kansas City, Missouri

Summit Medical Group Cancer Center ( Site 0007), Florham Park, New Jersey

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016), Hackensack, New Jersey

Roswell Park Cancer Institute ( Site 0023), Buffalo, New York

Consultants in Medical Oncology and Hematology (CMOH) ( Site 8002), Broomall, Pennsylvania

Cancer Care Associates Of York ( Site 0005), York, Pennsylvania

Tennessee Oncology-Chattanooga ( Site 0045), Chattanooga, Tennessee

TENNESSEE ONCOLOGY ( Site 0031), Nashville, Tennessee

Texas Oncology - Central/South Texas ( Site 8008), Austin, Texas

The Center for Cancer and Blood Disorders ( Site 0032), Fort Worth, Texas

Texas Oncology - San Antonio ( Site 8006), San Antonio, Texas

Texas Oncology - Northeast Texas ( Site 8012), Tyler, Texas

Inova Schar Cancer Institute ( Site 0015), Fairfax, Virginia

Virginia Commonwealth University (VCU) Medical Center ( Site 0030), Richmond, Virginia

Medical Oncology Associates, PS (dba Summit Cancer Centers) ( Site 0010), Spokane, Washington

University Hospital and UW Health Clinics ( Site 0006), Madison, Wisconsin

Royal North Shore Hospital ( Site 2806), St Leonards, New South Wales

AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 0205), Mechelen, Antwerpen

UZ Leuven-Hematology ( Site 0200), Leuven, Vlaams-Brabant

Hospital 9 De Julho ( Site 2206), São Paulo, Sao Paulo

Instituto Nacional de Câncer - INCA ( Site 2201), Rio de Janeiro, Not set

Hospital Paulistano-Americas Oncologia ( Site 2202), Sao Paulo, Not set

BC Cancer Kelowna ( Site 0112), Kelowna, British Columbia

BC Cancer Victoria ( Site 0109), Victoria, British Columbia

William Osler Health System ( Site 0103), Brampton, Ontario

The Ottawa Hospital - General Campus ( Site 0102), Ottawa, Ontario

McGill University Health Centre ( Site 0106), Montréal, Quebec

Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski ( Site 0100), Rimouski, Quebec

Bradfordhill-Clinical Area ( Site 2310), Santiago., Region M. De Santiago

FALP-UIDO ( Site 2300), Santiago, Region M. De Santiago

Clínica Alemana de Santiago-Unidad de Investigaciones ( Site 2306), Santiago, Region M. De Santiago

Anhui Provincial Cancer Hospital ( Site 2001), Hefei, Anhui

Peking University First Hospital ( Site 2022), Beijing, Beijing

Peking University Third Hospital-Hematology ( Site 2011), Beijing, Beijing

Chongqing University Cancer Hospital ( Site 2041), Chongqing, Chongqing

Southern Medical University Nanfang Hospital-Department of Hematopathology ( Site 2006), Guangzhou, Guangdong

Sun Yat-sen University Cancer Center ( Site 2028), Guangzhou, Guangdong

Liuzhou People's Hospital ( Site 2029), Liuzhou, Guangxi

Guangxi Medical University Affiliated Tumor Hospital ( Site 2004), Nanning, Guangxi

The Affiliated Hospital of Guizhou Medical University ( Site 2024), Guiyang, Guizhou

Hainan General Hospital ( Site 2018), Haikou, Hainan

Wuhan Union Hospital ( Site 2015), Wuhan, Hebei

Henan Cancer Hospital-hematology department ( Site 2025), Zhengzhou, Henan

Tongji Hospital Affiliated to Tongji Medical College of HUST ( Site 2016), Wuhan, Hubei

Hunan Cancer Hospital ( Site 2020), Changsha, Hunan

The Second Xiangya Hospital of Central South University ( Site 2010), Changsha, Hunan

Jiangsu Province Hospital ( Site 2000), Nanjing, Jiangsu

The First Affliated Hospital of Suzhou University ( Site 2027), Suzhou, Jiangsu

The Affiliated Hospital of Xuzhou Medical College ( Site 2013), Xuzhou, Jiangsu

The First Affiliated Hospital of Nanchang University ( Site 2023), Nanchang, Jiangxi

Jiangxi Provincial Cancer Hospital ( Site 2009), Nanchang, Jiangxi

The First Hospital of Jilin University-Hematology ( Site 2030), Changchun, Jilin

Shaanxi provincial people's hospital ( Site 2012), Xian, Shaanxi

Shandong Cancer Hospital ( Site 2003), Jinan, Shandong

Shanxi Cancer Hospital ( Site 2033), Taiyuan, Shanxi

West China Hospital, Sichuan University-Head and Neck Oncology ( Site 2026), Cheng Du, Sichuan

Tianjin Medical University Cancer Institute & Hospital-lymphoma ( Site 2019), Tianjin, Tianjin

Institute of hematology&blood disease hospital-Lymphoma ( Site 2005), Tianjin, Tianjin

Xinjiang Medical University Cancer Hospital - Urumqi ( Site 2014), Urumqi, Xinjiang

The first Affiliated Hospital, Zhejiang University School of Medicine-Hematology ( Site 2002), Hangzhou, Zhejiang

Zhejiang Cancer Hospital ( Site 2017), Hangzhou, Zhejiang

Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 2405), Valledupar, Cesar

IMAT S.A.S ( Site 2401), Monteria, Cordoba

Fundacion Valle del Lili- CIC-Oncology CIC ( Site 2402), Cali, Valle Del Cauca

Fakultni nemocnice Hradec Kralove-IV. interni hematologicka klinika ( Site 0301), Hradec Kralove, Not set

Fakultni nemocnice Olomouc ( Site 0303), Olomouc, Not set

Vseobecna fakultni nemocnice v Praze-I. Interní klinika - klinika hematologie ( Site 0302), Praha 2, Not set

Aalborg Universitetshospital, Syd ( Site 0403), Aalborg, Nordjylland

Roskilde Sygehus-Department of Hematology ( Site 0402), Roskilde, Sjaelland

Odense Universitetshospital-Department of Hematology ( Site 0401), Odense C, Syddanmark

Universitaetsklinikum Ulm. ( Site 0601), Ulm, Baden-Wurttemberg

VK&K Studien GbR ( Site 0607), Landshut, Bayern

Kliniken Maria Hilf ( Site 0603), Mönchengladbach, Nordrhein-Westfalen

InVO Institut für Versorgungsforschung in der Onkologie ( Site 0606), Koblenz, Rheinland-Pfalz

Universitätsklinikum Halle ( Site 0604), Halle, Sachsen-Anhalt

Onkologische Schwerpunktpraxis Kurfuerstendamm ( Site 0600), Berlin, Not set

University Hospital of Alexandroupolis ( Site 0701), Alexandroupolis, Anatoliki Makedonia Kai Thraki

Evangelismos General Hospital of Athens ( Site 0700), Athens, Attiki

General Hospital of Athens "Laiko" ( Site 0704), Athens, Attiki

University Hospital of Ioannina ( Site 0702), Ioannina, Not set

Queen Mary Hospital ( Site 3300), Hong Kong, Not set

Rambam Health Care Campus-Hematology and Bone Marrow Transplantation ( Site 1503), Haifa, Not set

Bnai Zion Medical Center ( Site 1505), Haifa, Not set

Hadassah Medical Center-Hemato-Oncology ( Site 1500), Jerusalem, Not set

Rabin Medical Center ( Site 1504), Petah Tikva, Not set

Sheba Medical Center-Hemato Oncology ( Site 1501), Ramat Gan, Not set

Yitzhak Shamir Medical Center. ( Site 1506), Zerifin, Not set

Nagoya University Hospital ( Site 1907), Nagoya, Aichi

Gunma University Hospital ( Site 1903), Maebashi, Gunma

Hokkaido University Hospital ( Site 1900), Sapporo, Hokkaido

Kobe City Medical Center General Hospital ( Site 1910), Kobe, Hyogo

Tohoku University Hospital ( Site 1901), Sendai, Miyagi

Kindai University Hospital ( Site 1909), Sayama, Osaka

Shimane University Hospital ( Site 1911), Izumo, Shimane

Cancer Institute Hospital of JFCR ( Site 1906), Koto, Tokyo

Chiba Cancer Center ( Site 1905), Chiba, Not set

Kyushu University Hospital ( Site 1914), Fukuoka, Not set

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital ( Site 1913), Hiroshima, Not set

Okayama University Hospital ( Site 1912), Okayama, Not set

Japanese Red Cross Osaka Hospital ( Site 1908), Osaka, Not set

Yamagata University Hospital ( Site 1902), Yamagata, Not set

University Malaya Medical Centre ( Site 1604), Lembah Pantai, Kuala Lumpur

Hospital Pulau Pinang ( Site 1602), George Town, Pulau Pinang

Queen Elizabeth Hospital ( Site 1603), Kota Kinabalu, Sabah

Centro de Infusion Superare ( Site 2602), Ciudad de México, Distrito Federal

Health Pharma Professional Research S.A. de C.V: ( Site 2608), Ciudad de México, Distrito Federal

Waikato Hospital-Haematology ( Site 3202), Hamilton, Waikato

North Shore Hospital-Department of Haematology ( Site 3200), Auckland, Not set

Aotearoa Clinical Trials ( Site 3201), Auckland, Not set

Akershus Universitetssykehus ( Site 0902), Lørenskog, Akershus

Sykehuset i Vestfold ( Site 0903), Toensberg, Vestfold

Oslo Universitetssykehus Rikshospitalet-Avdeling for blodsykdommer ( Site 0901), Oslo, Not set

Centro Medico Monte Carmelo-Oncology ( Site 2706), Arequipa, Ariqipa

Clínica Anglo Americana ( Site 2701), Lima, Not set

Uniwersytecki Szpital Kliniczny nr 1 w Lublinie-Oddział Hematoonkologii-Transplantacji Szpiku i Chem ( Site 1006), Lublin, Lubelskie

Pratia MCM Krakow ( Site 1007), Krakow, Malopolskie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site 1004), Warszawa, Mazowieckie

Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 1011), Gdansk, Pomorskie

Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku-Oddział Hematologii i Transplantacji ( Site 1013), Słupsk, Pomorskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1000), Gliwice, Slaskie

Pratia Onkologia Katowice ( Site 1009), Katowice, Slaskie

Samodzielny Publiczny Zakład Opieki Zdrowotnej MSWiA w Olsztynie-Oddzial Kliniczny Hematologii ( Site 1005), Olsztyn, Warminsko-mazurskie

Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 3103), Lisbon, Lisboa

Champalimaud Foundation ( Site 3102), Lisbon, Lisboa

Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 3107), Vila Nova de Gaia, Porto

Unidade Local de Saude Lisboa Ocidental - Hospital de São Francisco Xavier ( Site 3104), Lisboa, Not set

Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 3106), Lisboa, Not set

Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 3100), Porto, Not set

Netcare Pretoria East Hospital-Alberts Cellular Therapy ( Site 1101), Centurion, Gauteng

Wits Clinical Research ( Site 1102), Johannesburg, Gauteng

Groote Schuur Hospital-Clinical Haematology ( Site 1100), Cape Town, Western Cape

Haemalife ( Site 1105), Kuilsriver, Western Cape

Constantiaberg Haematology ( Site 1106), Plumstead, Western Cape

Institut Català d'Oncologia - L'Hospitalet-Haematology Department ( Site 1207), L'Hospitalet Del Llobregat, Barcelona

HOSPITAL CLÍNIC DE BARCELONA ( Site 1202), Barcelona, Cataluna

HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA ( Site 1208), Majadahonda, Madrid, Comunidad De

HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1209), Pozuelo de Alarcon, Madrid

hospital universitario de canarias ( Site 1205), La Laguna, Santa Cruz De Tenerife

Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1206), Barcelona, Not set

Hospital Universitario de Salamanca - Complejo Asistencial U-Servicio de Hematologia ( Site 1201), Salamanca, Not set

Karolinska Universitetssjukhuset Solna ( Site 1302), Stockholm, Stockholms Lan

Chang Gung Memorial Hospital at Kaohsiung-Division of Hematology and Oncology ( Site 1702), Kaohsiung, Not set

National Cheng Kung University Hospital ( Site 1700), Tainan, Not set

National Taiwan University Hospital ( Site 1701), Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch ( Site 1703), Taoyuan, Not set

Maharaj Nakorn Chiang Mai Hospital ( Site 1800), Muang, Chiang Mai

Chulalongkorn University ( Site 1802), Bangkok, Krung Thep Maha Nakhon

Faculty of Medicine Siriraj Hospital-Division of Hematology, Department of Medicine ( Site 1801), Bangkok, Krung Thep Maha Nakhon

Naresuan University Hospital ( Site 1804), Muang, Phitsanulok

Songklanagarind hospital ( Site 1803), HatYai, Songkhla

Ankara Universitesi Tip Fakultesi Hastanesi-hematology ( Site 1401), Ankara, Not set

Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1407), Ankara, Not set

Antalya Egitim ve Arastırma Hastanesi ( Site 1409), Antalya, Not set

Trakya University-Balkan Onkoloji Hastanesi ( Site 1403), Edirne, Not set

Marmara Universitesi Pendik Egitim Arastirma Hastanesi ( Site 1408), Istanbul, Not set

Ege Universitesi Hastanesi ( Site 1404), İzmir, Not set

Ondokuz Mays Üniversitesi ( Site 1410), Samsun, Not set

Southmead Hospital ( Site 3010), Bristol, Bristol, City Of

St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 3006), London, London, City Of

The Churchill Hospital ( Site 3007), Oxford, Oxfordshire

GenesisCare - Bristol ( Site 3011), Bristol, South Gloucestershire

GenesisCare - Cambridge ( Site 3001), Newmarket, Suffolk

GenesisCare - Windsor ( Site 3002), Windsor, Windsor And Maidenhead

Barnet Hospital ( Site 3005), Barnet, Not set

St James's University Hospital ( Site 3004), Leeds, Not set

City Hospital, Nottingham University Hospitals NHS Trust ( Site 3003), Nottingham, Not set

Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Learn More ›

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

NCT05797168

Recruiting

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced tumors

Gender:

ALL

Ages:

Between 18 years and 130 years

Trial Updated:

07/23/2025

Locations: Research Site, Duarte, California +58 locations

Research Site, Duarte, California

Research Site, Irvine, California

Research Site, La Jolla, California

Research Site, Aurora, Colorado

Research Site, Louisville, Kentucky

Research Site, Boston, Massachusetts

Research Site, Detroit, Michigan

Research Site, Columbus, Ohio

Research Site, Portland, Oregon

Research Site, Providence, Rhode Island

Research Site, Houston, Texas

Research Site, Fairfax, Virginia

Research Site, Liverpool, Not set

Research Site, Melbourne, Not set

Research Site, Edmonton, Alberta

Research Site, London, Ontario

Research Site, Toronto, Ontario

Research Site, Montréal, Quebec

Research Site, Chengdu, Not set

Research Site, Chongqing, Not set

Research Site, Guangzhou, Not set

Research Site, Jinan, Not set

Research Site, Xi'an, Not set

Research Site, Zhengzhou, Not set

Research Site, Berlin, Not set

Research Site, Essen, Not set

Research Site, Hannover, Not set

Research Site, Leipzig, Not set

Research Site, Mannheim, Not set

Research Site, Regensburg, Not set

Research Site, Haifa, Not set

Research Site, Ramat Gan, Not set

Research Site, Hidaka-shi, Not set

Research Site, Kashiwa, Not set

Research Site, Koto-ku, Not set

Research Site, Sunto-gun, Not set

Research Site, Tokyo, Not set

Research Site, Seoul, Not set

Research Site, Barcelona, Not set

Research Site, Madrid, Not set

Research Site, Málaga, Not set

Research Site, Taichung, Not set

Research Site, Tainan City, Not set

Research Site, Taipei, Not set

Research Site, Ankara, Not set

Research Site, Istanbul, Not set

Research Site, Cambridge, Not set

Research Site, Glasgow, Scotland, Not set

Research Site, London, Not set

Research Site, Sutton, Not set

Conditions: Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer

Learn More ›